All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A11714" target="_blank" >RIV/00216208:11110/12:11714 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1007/s10787-011-0111-7" target="_blank" >http://dx.doi.org/10.1007/s10787-011-0111-7</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors

  • Original language description

    This paper reviews new drug targets in the treatment of depression and new drug candidates to treat depression. We suppose that antidepressants tend to normalize six main pathways. Targeting these pathways has the potential to yield antidepressant effects, e.g. using cytokine antagonists, Cox-2 inhibitors, statins, acetylsalicylic acid, ketamine, omega3 poly-unsaturated fatty acids, antioxidants, and neurotrophic factors. We suggest that novel therapies could be developed that target these six pathwayssimultaneously.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Inflammopharmacology

  • ISSN

    0925-4692

  • e-ISSN

  • Volume of the periodical

    20

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    24

  • Pages from-to

    127-150

  • UT code for WoS article

  • EID of the result in the Scopus database